Kilgallon Kevin B, Leroue Matthew, Shankman Sara, Shea Taryn, Buckvold Shannon, Mitchell Max, Morgan Gareth, Zablah Jenny, Maddux Aline B
From the Department of Pediatrics, Case Western University School of Medicine, Rainbow Babies and Children's Hospital, Cleveland, Ohio.
Department of Pediatrics, Section of Critical Care, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado.
ASAIO J. 2025 Apr 1;71(4):e66-e71. doi: 10.1097/MAT.0000000000002281. Epub 2024 Jul 25.
During the coronavirus 2019 (COVID-19) pandemic, children suffered severe lung injury resulting in acute respiratory distress syndrome requiring support with extracorporeal membrane oxygenation (ECMO). In this case series, we described our center's experience employing a rehabilitation-focused ECMO strategy including extubation during ECMO support in four pediatric patients with acute COVID-19 pneumonia hospitalized from September 2021 to January 2022. All four patients tolerated extubation within 30 days of ECMO initiation and achieved mobility while on ECMO support. Duration of ECMO support was 35-152 days and hospital lengths of stay were 52-167 days. Three of four patients survived. Two of three survivors had normal functional status at discharge except for ongoing respiratory support. The third survivor had significant motor deficits due to critical illness polyneuropathy and was supported with daytime oxygen and nocturnal noninvasive support. Overall, these patients demonstrated good outcomes and tolerance of a rehabilitation-focused ECMO strategy.
在2019年冠状病毒病(COVID-19)大流行期间,儿童遭受了严重的肺损伤,导致急性呼吸窘迫综合征,需要体外膜肺氧合(ECMO)支持。在这个病例系列中,我们描述了我们中心采用以康复为重点的ECMO策略的经验,包括在2021年9月至2022年1月住院的4例急性COVID-19肺炎儿科患者的ECMO支持期间进行拔管。所有4例患者在ECMO启动后30天内耐受拔管,并在ECMO支持期间实现了活动能力。ECMO支持时间为35 - 152天,住院时间为52 - 167天。4例患者中有3例存活。3名幸存者中有2例出院时功能状态正常,但仍需持续呼吸支持。第三名幸存者因危重病性多发性神经病存在明显的运动缺陷,需要日间吸氧和夜间无创支持。总体而言,这些患者展示了以康复为重点的ECMO策略的良好结果和耐受性。